InvestorsHub Logo
Followers 12
Posts 788
Boards Moderated 0
Alias Born 12/21/2017

Re: None

Tuesday, 01/19/2021 12:22:40 AM

Tuesday, January 19, 2021 12:22:40 AM

Post# of 233240
“Based on the information publicly available as of November 2020, 44 antibody therapeutics are in late-stage clinical studies for non-cancer indications, including 6 for COVID-19, and marketing applications for at least 6 (leronlimab, tezepelumab, faricimab, ligelizumab, garetosmab, and fasinumab) are planned in 2021.”

https://pubmed.ncbi.nlm.nih.gov/33459118/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News